North Star Asset Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $965K | Sell |
6,158
-63
| -1% | -$9.44K | 0.04% | 202 |
|
|
2026
Q1 | $950K | Hold |
6,221
| – | – | 0.04% | 196 |
|
|
2025
Q4 | $858K | Buy |
6,221
+169
| +3% | +$22.1K | 0.03% | 195 |
|
|
2025
Q3 | $776K | Hold |
6,052
| – | – | 0.03% | 202 |
|
|
2025
Q2 | $732K | Buy |
6,052
+1,276
| +27% | +$144K | 0.03% | 199 |
|
|
2025
Q1 | $532K | Sell |
4,776
-100
| -2% | -$10.6K | 0.02% | 215 |
|
|
2024
Q4 | $474K | Hold |
4,876
| – | – | 0.02% | 221 |
|
|
2024
Q3 | $561K | Sell |
4,876
-75
| -2% | -$8.51K | 0.03% | 210 |
|
|
2024
Q2 | $527K | Hold |
4,951
| – | – | 0.03% | 210 |
|
|
2024
Q1 | $479K | Hold |
4,951
| – | – | 0.02% | 220 |
|
|
2023
Q4 | $500K | Hold |
4,951
| – | – | 0.03% | 206 |
|
|
2023
Q3 | $504K | Sell |
4,951
-75
| -1% | -$7.61K | 0.03% | 204 |
|
|
2023
Q2 | $507K | Hold |
5,026
| – | – | 0.03% | 210 |
|
|
2023
Q1 | $462K | Hold |
5,026
| – | – | 0.03% | 213 |
|
|
2022
Q4 | $456K | Hold |
5,026
| – | – | 0.03% | 212 |
|
|
2022
Q3 | $382K | Hold |
5,026
| – | – | 0.03% | 214 |
|
|
2022
Q2 | $425K | Hold |
5,026
| – | – | 0.03% | 207 |
|
|
2022
Q1 | $441K | Buy |
5,026
+25
| +0.5% | +$2.17K | 0.02% | 215 |
|
|
2021
Q4 | $437K | Hold |
5,001
| – | – | 0.02% | 221 |
|
|
2021
Q3 | $409K | Buy |
5,001
+575
| +13% | +$51.7K | 0.02% | 224 |
|
|
2021
Q2 | $404K | Sell |
4,426
-46
| -1% | -$4.1K | 0.02% | 222 |
|
|
2021
Q1 | $382K | Hold |
4,472
| – | – | 0.02% | 218 |
|
|
2020
Q4 | $422K | Sell |
4,472
-811
| -15% | -$70.9K | 0.03% | 205 |
|
|
2020
Q3 | $459K | Buy |
5,283
+375
| +8% | +$32.5K | 0.03% | 187 |
|
|
2020
Q2 | $429K | Sell |
4,908
-22
| -0.4% | -$1.9K | 0.03% | 190 |
|
|
2020
Q1 | $406K | Sell |
4,930
-1,788
| -27% | -$160K | 0.04% | 189 |
|
|
2019
Q4 | $636K | Buy |
6,718
+54
| +0.8% | +$4.84K | 0.05% | 183 |
|
|
2019
Q3 | $579K | Sell |
6,664
-44
| -0.7% | -$3.95K | 0.05% | 185 |
|
|
2019
Q2 | $613K | Sell |
6,708
-803
| -11% | -$68K | 0.05% | 187 |
|
|
2019
Q1 | $647K | Sell |
7,511
-28
| -0.4% | -$2.25K | 0.05% | 178 |
|
|
2018
Q4 | $580K | Sell |
7,539
-87
| -1% | -$6.77K | 0.05% | 177 |
|
|
2018
Q3 | $589K | Sell |
7,626
-474
| -6% | -$35K | 0.05% | 196 |
|
|
2018
Q2 | $548K | Hold |
8,100
| – | – | 0.05% | 198 |
|
|
2018
Q1 | $587K | Hold |
8,100
| – | – | 0.05% | 190 |
|
|
2017
Q4 | $609K | Buy |
+8,100
| New | +$611K | 0.05% | 188 |
|
Other funds holding NVS
North Star Asset Management's NVS Position: Q2 2026 in Review
North Star Asset Management reduced its Novartis (NVS) stake by 1% in Q2 2026, selling an estimated $9.44K and leaving 6,158 shares worth $965K. The position accounts for 0.04% of the portfolio, ranked #202.
North Star Asset Management first reported a position in NVS in Q4 2017 and has held it in 35 quarters since. 1,617 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- North Star Asset Management held 6,158 shares of Novartis worth $965K as of Q2 2026.
- North Star Asset Management sold 63 Novartis shares in Q2 2026, an estimated $9.44K.
- Novartis made up 0.04% of North Star Asset Management's portfolio in Q2 2026, its #202 holding.
- North Star Asset Management first reported a position in Novartis in Q4 2017 and has held it in 35 quarters since.
- 1,617 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on North Star Asset Management's 13F filing for Q2 2026, filed 18 Aug 2026.